Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00320047 · ClinicalTrials.gov registry record · NA
Effectiveness of Baclofen in the Treatment of People With Bulimia Nervosa or Binge Eating Disorder
A NA study of Eating Disorders and Bulimia Nervosa, sponsored by New York State Psychiatric Institute.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT00320047 is a NA study of Eating Disorders and Bulimia Nervosa that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 10 participants, below the 322-participant average among 37 other Eating Disorders trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00320047, a NA study of Eating Disorders and Bulimia Nervosa, has completed, sponsored by New York State Psychiatric Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will evaluate the effectiveness of the drug baclofen in reducing binge eating and associated food cravings in people with bulimia nervosa or binge eating disorder.
Conditions Studied
Interventions
- DRUG Baclofen
Study Locations (1)
New York
- Eating Disorders Clinic, New York State Psychiatric Institute - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2005-04 |
| Est. Completion | 2007-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00320047
The ClinicalTrials.gov registry entry for NCT00320047 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 322-participant average among 37 other Eating Disorders trials with a reported enrollment target (97% lower). The listed sponsor is New York State Psychiatric Institute, which has 364 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Eating Disorders appearing as the primary indexed condition, and to 1 intervention - of which Baclofen is the first listed.
NCT00320047 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT00320047 about?
NCT00320047 is a clinical study titled "Effectiveness of Baclofen in the Treatment of People With Bulimia Nervosa or Binge Eating Disorder". This study will evaluate the effectiveness of the drug baclofen in reducing binge eating and associated food cravings in people with bulimia nervosa or binge eating disorder.
What is the current status of trial NCT00320047?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2005-04. Estimated completion is 2007-06.
What conditions does trial NCT00320047 study?
This clinical trial studies the following conditions: Eating Disorders, Bulimia Nervosa.
What interventions are being tested in trial NCT00320047?
The interventions under investigation include: Baclofen (DRUG).
Who is sponsoring clinical trial NCT00320047?
This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00320047 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Eating Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Facing Eating Disorder Fears for Anorexia Nervosa
RECRUITING · NA
-
Targeting Transdiagnostic Self-regulatory Factors and Eating Disorder Pathology Among Adults With BInge-spectrum Eating disOrders: A mHEALTH Interoceptive Exposure Intervention (the Bio-HEALTH Study)
RECRUITING · NA
-
Targeting Social Function in Anxiety and Eating Disorders
RECRUITING · NA
-
Diabetes Body Project 2
RECRUITING · NA
-
Acceptability and Feasibility of a Single-Session Online Parent-Focused Intervention Targeting Child Body Image Development
RECRUITING · NA
-
Developing an Artificial Intelligence (AI) Chatbot for Adolescents and Young Adults With Eating Disorders
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.